7th International Symposium on Translational Research in Oncology

At this premier scientific meeting, the world's leading researchers gather to present data and discuss recent directions in oncology research, with a focus on translating the most recent laboratory developments into the development of treatments that improve clinical outcomes for cancer patients. The program, developed under the direction of co-chairs Dennis J. Slamon, MD, PhD, and John Crown, MD, MPH, includes relevant didactic presentations and compelling, interactive discussions.

Faculty are carefully selected from among the researchers at the forefront of the translational work in the topic, whether from academia, government, or industry. The program encourages networking and interaction between the attendees and the renowned faculty members.

Location:

October 16 - 19, 2008
Hyatt Regency Huntington Beach
Huntington Beach, CA

Click here for more information and to register for this event

Cases in Point: Risk Factors, Surveillance Strategies, and Treatment Options for Hepatocellular Carcinoma

In this live and interactive CME-certified program, an expert faculty panel will discuss surveillance and ongoing screening for HCC in the hepatology setting, early identification of patients with HCC, and new management and therapeutic options for patients diagnosed with HCC.

Presented for attendees of the 59th AASLD Annual Meeting. This is not an official function/event of the American Association for the Study of Liver Diseases.

Available Dates:
Saturday, November 01, 2008

Click here for more information and to register for this event

Clinical Crossroads: Factors Critical to Successful Patient Management in Lymphomas, Myeloma, and Waldenström’s

This live satellite symposium will feature interactive cases based on the top concerns identified by the CCO membership in the treatment of multiple myeloma, non-Hodgkin’s lymphoma, and Waldenström’s macroglobulinemia.

Available Dates:
Friday, December 05, 2008

Click here for more information and to register for this event

Anthracyclines in Early Breast Cancer: An Expert Debate and Patient Perspective

Key opinion leaders present data, describe clinical cases, and participate in a debate of one of the greatest controversies today in the management of early breast cancer: when to use anthracycline- or nonanthracycline-containing regimens in patients with breast cancer. HER2-positive and HER2-negative cases will be explored.

Available Dates:
Friday, December 12, 2008

Click here for more information and to register for this event